152 related articles for article (PubMed ID: 12527402)
21. Gallstone formation and dissolution.
Coyne MJ; Schoenfield LJ
Prog Liver Dis; 1976; 5():622-35. PubMed ID: 775559
[No Abstract] [Full Text] [Related]
22. Discovery of the hepatic canalicular and intestinal cholesterol transporters. New targets for treatment of hypercholesterolemia.
Zanlungo S; Nervi F
Eur Rev Med Pharmacol Sci; 2003; 7(2):33-9. PubMed ID: 12911117
[TBL] [Abstract][Full Text] [Related]
23. Physical activity, biliary lipids, and gallstones in obese subjects.
Chuang CZ; Martin LF; LeGardeur BY; Lopez A
Am J Gastroenterol; 2001 Jun; 96(6):1860-5. PubMed ID: 11419840
[TBL] [Abstract][Full Text] [Related]
24. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model.
Moschetta A; Bookout AL; Mangelsdorf DJ
Nat Med; 2004 Dec; 10(12):1352-8. PubMed ID: 15558057
[TBL] [Abstract][Full Text] [Related]
25. Biliary lipid secretion.
Hişmioğullari AA; Bozdayi AM; Rahman K
Turk J Gastroenterol; 2007 Jun; 18(2):65-70. PubMed ID: 17602352
[TBL] [Abstract][Full Text] [Related]
26. The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump.
Gooijert KE; Havinga R; Wolters H; Wang R; Ling V; Tazuma S; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(5):G450-7. PubMed ID: 25552583
[TBL] [Abstract][Full Text] [Related]
27. Biliary cholesterol secretion: more than a simple ABC.
Dikkers A; Tietge UJ
World J Gastroenterol; 2010 Dec; 16(47):5936-45. PubMed ID: 21157969
[TBL] [Abstract][Full Text] [Related]
28. Intrahepatic biliary cholesterol and phospholipid transport in humans: effect of obesity and cholesterol cholelithiasis.
Ahmed HA; Jazrawi RP; Goggin PM; Dormandy J; Northfield TC
J Lipid Res; 1995 Dec; 36(12):2562-73. PubMed ID: 8847482
[TBL] [Abstract][Full Text] [Related]
29. [Biliary lipid secretion in men with cholelithiasis].
Covarrubias C; Antezana C; Severín C; Valdivieso V
Rev Med Chil; 1989 Nov; 117(11):1217-20. PubMed ID: 2519794
[TBL] [Abstract][Full Text] [Related]
30. Differences between hepatic and biliary lipid metabolism and secretion in genetically gallstone-susceptible and gallstone-resistant mice.
Xu G; Zhao L; Fuchs M
Chin Med J (Engl); 2002 Sep; 115(9):1292-5. PubMed ID: 12411097
[TBL] [Abstract][Full Text] [Related]
31. Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis.
Bertolotti M; Gabbi C; Anzivino C; Mitro N; Godio C; De Fabiani E; Crestani M; Del Puppo M; Ricchi M; Carulli L; Rossi A; Loria P; Carulli N
Eur J Clin Invest; 2006 Mar; 36(3):170-5. PubMed ID: 16506961
[TBL] [Abstract][Full Text] [Related]
32. Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis.
Lammert F; Wang DQ; Hillebrandt S; Geier A; Fickert P; Trauner M; Matern S; Paigen B; Carey MC
Hepatology; 2004 Jan; 39(1):117-28. PubMed ID: 14752830
[TBL] [Abstract][Full Text] [Related]
33. ABCB4 gene mutation-associated cholelithiasis in adults.
Rosmorduc O; Hermelin B; Boelle PY; Parc R; Taboury J; Poupon R
Gastroenterology; 2003 Aug; 125(2):452-9. PubMed ID: 12891548
[TBL] [Abstract][Full Text] [Related]
34. Cholesterol-holding capacity of bile in relation to gallstone formation.
Nakayama F
Clin Chim Acta; 1966 Aug; 14(2):171-6. PubMed ID: 5967165
[No Abstract] [Full Text] [Related]
35. [APOE gene polimorphism and lithogenicity of the bile in the women with cholelithiasis].
Grigor'eva IN; Nikitenko TM; Shakhtshneĭder EV; Kulikov IV; Voevoda MI
Eksp Klin Gastroenterol; 2009; (8):56-60. PubMed ID: 20469680
[TBL] [Abstract][Full Text] [Related]
36. [Cholesterol gallstone pathogenesis].
Méndez N; Uribe M; Jessurun J; Uscanga L
Rev Invest Clin; 1990 Jul; 42 Suppl():53-7. PubMed ID: 19256135
[TBL] [Abstract][Full Text] [Related]
37. Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and counteracts cholelithiasis in the genetically prone C57L/J mouse.
Clarke GA; Bouchard G; Paigen B; Carey MC
Gut; 2004 Jan; 53(1):136-42. PubMed ID: 14684588
[TBL] [Abstract][Full Text] [Related]
38. Some aspects of gallstone: a clinico-biochemical correlation.
Hamid MA
West Afr J Pharmacol Drug Res; 1975 Jun; 2(1):38-47. PubMed ID: 1226731
[TBL] [Abstract][Full Text] [Related]
39. Genetic defects in hepatocanalicular transport.
Thompson R; Jansen PL
Semin Liver Dis; 2000; 20(3):365-72. PubMed ID: 11076402
[TBL] [Abstract][Full Text] [Related]
40. Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol.
Heverin M; Meaney S; Brafman A; Shafir M; Olin M; Shafaati M; von Bahr S; Larsson L; Lövgren-Sandblom A; Diczfalusy U; Parini P; Feinstein E; Björkhem I
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2191-7. PubMed ID: 17761942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
